CDKN2A and vulva cancer: Several studies were published assessing the prognostic role of HPV-driven carcinogenesis in vulvar cancer, most of them using either p16INK4a-overexpression (17–20) or HPV DNA (17, 18, 21–23) as marker for HPV-driven carcinogenesis.